Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients

Clinical trial NCT05468359 · RECRUITING

Trial details

NCT number: NCT05468359
Sponsor: St. Jude Children's Research Hospital
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Refractory Solid Tumor Hepatocellular Carcinoma Malignant Solid Tumor Pediatric Cancer Pediatric Solid Tumor Fibrolamellar Carcinoma

Start date: 2022-11-07
Primary completion: 2032-06-01
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.